Cummings Keith Lamont's Form 4 filing
Pliant Therapeutics, Inc. (PLRX) · filed Jul 12, 2024
- Accession no.
- 0001746473-24-000125
- Filed
- Jul 12, 2024
- Trade date
- Jul 10, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $126.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cummings Keith LamontCIK 0001809204 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 10, 2024 | Common Stock | SSaleDisposed | −10,911 | $11.56 | −$126,131.16 | 282,115 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.